50
Views
0
CrossRef citations to date
0
Altmetric
Commentaries

Improving patient access to modern myeloma therapy in Latin America: first step, know what your problem really is

&
Pages 3033-3034 | Received 24 Aug 2020, Accepted 28 Aug 2020, Published online: 24 Sep 2020

References

  • Martin G. Gabriel García Márquez: a life. 1st ed. United States: Vintage Books; 2010.
  • Pena C, Riva E, Schutz N, et al. Different outcomes for transplant-eligible newly diagnosed multiple myeloma patients in Latin America according to the public versus private management: a GELAMM study. Leukemia and Lymphoma. 2020; 61(13):3112–3119.
  • Schmikla H, Ravi G, de Lima M, et al. Stem cell transplant minimizes insurance coverage-driven outcome disparities for multiple myeloma patients. Biol Blood Marrow Transplant. 2020;26(3):S46.
  • Experts in Chronic Myeloid Leukemia. The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts. Blood. 2013; 121(22):4439–4442.
  • Rosenberg T. Look at Brazil. 1/28/2001. [cited 2020 Aug 14]. Available from: https://www.nytimes.com/2001/01/fig28/magazine/look-at-brazil.html

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.